![Andrea Grant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Andrea Grant served as the Chief Executive Officer, Executive Director & MD at Algorae Pharmaceuticals Ltd. from 2012 to 2014.
Prior to that, she was the Chief Executive Officer at Diatranz Otsuka Ltd. and the Managing Director at Galapagos Genomics NV.
Dr. Grant received her undergraduate and doctorate degrees from the University of Cambridge.
Eerdere bekende functies van Andrea Grant
| Bedrijven | Functie | Einde |
|---|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Algemeen Directeur | 01-04-2014 |
Galapagos Genomics NV
 Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Develops drugs | Corporate Officer/Principal | 02-05-2008 |
Diatranz Otsuka Ltd.
 Diatranz Otsuka Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Directeur | - |
Opleiding van Andrea Grant
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Algorae Pharmaceuticals Ltd.
 Algorae Pharmaceuticals Ltd. Pharmaceuticals: OtherHealth Technology Develops living cell products for the treatment of diabetes and neurological diseases | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galapagos Genomics NV
Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Diatranz Otsuka Ltd.
Diatranz Otsuka Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
